3t-(3-amino-phenyl)-2-methyl-acrylic acid | 103205-22-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: 3t-(3-amino-phenyl)-2-methyl-acrylic acid
• 英文别名: 3-(3-amino-phenyl)-2-methyl-acrylic acid；3t-(3-Amino-phenyl)-2-methyl-acrylsaeure；3-(3-Amino-phenyl)-2-methyl-acrylsaeure；3-Amino-α-methyl-zimtsaeure；β-(3-Amino-phenyl)-methacrylsaeure；α-(3-Amino-benzal)-propionsaeure；(E)-3-(3-aminophenyl)-2-methylprop-2-enoic acid
• CAS: 103205-22-7
• 化学式: C₁₀H₁₁NO₂
• 分子量: 177.203
• InChiKey: WCPNDHITXVUFFM-FNORWQNLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  63.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3t-(3-amino-phenyl)-2-methyl-acrylic acid 在 磷化氢 、 氢碘酸 作用下， 生成 3-(3-benzoylamino-phenyl)-2-methyl-propionic acid
  参考文献：
  名称：

  v. Miller; Rohde, Chemische Berichte, 1890, vol. 23, p. 1899

  摘要：

  DOI：
• 作为产物：
  描述：

  2-甲基-3-(3-硝基苯基)丙烯酸 在 乙醇 、 铂 作用下， 生成 3t-(3-amino-phenyl)-2-methyl-acrylic acid
  参考文献：
  名称：

  Nerdel; John, Chemische Berichte, 1956, vol. 89, p. 1945,1949

  摘要：

  DOI：

文献信息

• Isoimide containing oligomers
  申请人：Hughes Aircraft Company

  公开号：EP0071372A1

  公开（公告）日：1983-02-09

  A class of relatively low molecular-weight oligomers containing at least one isoimide group and terminal groups capable of undergoing an addition polymerization reaction. The oligomers of the present invention are characterized by excellent solubility in common solvents and a melting temperature considerably lower than their cure temperature, thus enabling the oligomers to be formed into cured polymers more slowly and at lower temperatures, all without the evolution of deleterious gases.

  一类相对低分子量的低聚物，含有至少一个异亚胺基团和能够发生加成聚合反应的末端基团。 本发明低聚物的特点是在普通溶剂中具有极佳的溶解性，熔化温度大大低于其固化温度，从而使低聚物能够在更低的温度下更慢地形成固化聚合物，且不会产生有害气体。
• Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them
  申请人：AMANO PHARMACEUTICAL CO., LTD.

  公开号：EP0166542A2

  公开（公告）日：1986-01-02

  A triterpenyl ester of organic acid other than triterpenyl esters of ferulic acid and of monobasic and dibasic saturated fatty acids. A process for producing a triterpenyl ester of organic acid other than esters of ferulic acid and of monobasic and dibasic saturated fatty acids, which comprises the reaction of a triterpenyl alcohol with an acid halide of the corresponding organic acid. A pharmaceutical composition for treatment of hyperlipidemia comprising a pharmaceutical carrier and an effective amount of a triterpenyl ester of organic acid other than triterpenyl esters of dibasic saturated fatty acids. A pharmaceutical composition for treating hyperlipidemia which comprises a pharmaceutical carrier and an effective amount of cyclobranol as an active ingredient.

  一种除阿魏酸三萜酯和单盐基及二盐基饱和脂肪酸三萜酯以外的有机酸三萜酯。一种除阿魏酸酯、单基和二基饱和脂肪酸酯以外的有机酸三萜酯的生产工艺，包括三萜醇与相应有机酸的酸卤化物反应。一种治疗高脂血症的药物组合物，包括药物载体和有效量的有机酸三萜酯（二元饱和脂肪酸三萜酯除外）。一种治疗高脂血症的药物组合物，它包括一种药物载体和有效量的作为活性成 分的环烷醇。
• CURED FILM FORMATION COMPOSITION, ORIENTATION MATERIAL, AND PHASE DIFFERENCE MATERIAL
  申请人：Nissan Chemical Industries, Ltd.

  公开号：EP2767562A1

  公开（公告）日：2014-08-20

  There is provided a cured-film formation composition that forms a cured film having excellent photoreaction efficiency and solvent resistance, and high adhesion, an orientation material for photo-alignment, and a retardation material formed with the orientation material. The cured-film formation composition comprises a component (A) that is a compound having a photo-aligning group and one substituent selected from a hydroxy group, a carboxy group, and an amino group; a component (B) that is a hydrophilic polymer having one or more substituents selected from a hydroxy group, a carboxy group, and an amino group; and a component (C) that is a cross-linking agent that reacts with the component (A) and the component (B) and reacts at a temperature lower than a sublimation temperature of the component (A), wherein when the component (B) is an acrylic polymer, the cured-film formation composition further comprises a component (E) that is an adhesion enhancing component. The cross-linking agent of the component (C) may be more hydrophilic than the component (A). The orientation material is formed by forming a cured film with the cured-film formation composition and utilizing photo-alignment technique. The retardation material is obtained by applying a polymerizable liquid crystal on the orientation material and curing it.

  本发明提供了一种固化成膜组合物，该组合物可形成具有优异光反应效率和耐溶剂性以及高附着力的固化膜，还提供了一种用于光配位的配向材料，以及一种与配向材料形成的延缓材料。固化成膜组合物包括：组分（A），即具有光配位基团和一个选自羟基、羧基和氨基的取代基的化合物；组分（B），即具有一个或多个选自羟基、羧基和氨基的取代基的亲水性聚合物；和一种成分（C），它是一种交联剂，可与成分（A）和成分（B）反应，反应温度低于成分（A）的升华温度，其中当成分（B）是丙烯酸聚合物时，固化成膜组合物还包括一种成分（E），它是一种附着力增强成分。组分（C）的交联剂可能比组分（A）更亲水。定向材料是通过使用固化成膜组合物形成固化膜并利用光对准技术形成的。将可聚合液晶涂抹在取向材料上并使其固化，即可获得缓凝材料。
• CURED FILM FORMATION COMPOSITION, ORIENTATION MATERIAL, AND RETARDATION MATERIAL
  申请人：NISSAN CHEMICAL INDUSTRIES, LTD.

  公开号：US20140239240A1

  公开（公告）日：2014-08-28

  There is provided a cured-film formation composition that forms a cured film having excellent photoreaction efficiency and solvent resistance, and high adhesion, an orientation material for photo-alignment, and a retardation material formed with the orientation material.
• CURED-FILM FORMATION COMPOSITION, ORIENTATION MATERIAL, AND RETARDATION MATERIAL
  申请人：NISSAN CHEMICAL INDUSTRIES, LTD.

  公开号：US20150191572A1

  公开（公告）日：2015-07-09

  A cured-film formation composition for forming a cured film having photoreaction efficiency and solvent resistance, and high adhesiveness alignment uniformity, and an orientation material for photo-alignment, and a retardation material formed by use of the orientation material. A cured-film formation composition includes (A) a compound having a photo-aligning group and one substituent selected from a hydroxy group, a carboxy group, and an amino group; (B) a hydrophilic polymer having one or more substituents selected from a hydroxy group, a carboxy group, and an amino group; and (C) a polymer obtained by polymerizing a monomer including an N-hydroxymethyl compound or an N-alkoxymethyl (meth)acrylamide compound, and optionally further a cross-linking catalyst as a component (D). By use of the composition, a cured-film is formed and an orientation material is formed by utilizing photo-alignment technique. A retardation material is obtained by applying a polymerizable liquid crystal on the orientation material and curing it.